← Back to Search

mHealth App for High Blood Pressure (myBPmyLife Trial)

N/A
Waitlist Available
Led By Brahmajee K Nallamothu, MD
Research Sponsored by University of Michigan
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, up to 6 months
Awards & highlights

Summary

This trial uses a smartwatch and a phone app to help people with high blood pressure be more active and eat less salt by sending them reminders. The goal is to see if these reminders can help lower their blood pressure.

Who is the study for?
This trial is for English-speaking adults with high blood pressure who haven't changed their hypertension medication in the last month. They must own a smartphone compatible with the myBPmyLife app and have internet access. People can't join if they're advised against exercise or low-sodium diets, have very high blood pressure, secondary causes of hypertension, heart failure, kidney disease, issues using a blood pressure cuff or smartwatch due to size, consume less than 1500 mg/day sodium, or are currently/potentially pregnant.
What is being tested?
The study tests whether notifications from a smartwatch and mobile app (myBPmyLife) help people with high blood pressure increase physical activity and reduce salt intake. Participants will be randomly assigned to either receive these interventions through the app or placed in a control group without such features.
What are the potential side effects?
Since this trial involves lifestyle changes delivered via an app rather than medication, side effects may include discomfort from increased physical activity or dietary adjustments but no medicinal side effects are expected.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, up to 6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, up to 6 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Secondary study objectives
Change in quality-of-life between baseline and 6-months as assessed by the single-item Self-Rated Health (SRH) Questionnaire

Trial Design

2Treatment groups
Experimental Treatment
Group I: Dietary plus physical activity JITAIExperimental Treatment1 Intervention
Participants in the experimental group will be provided a smarthwatch and home blood pressure monitor. They will then receive the myBPmyLife app that includes push notifications to promote increased physical activity and improve low sodium food choices. The app also provides goal setting for weekly step count and information on low-sodium food choices, as well as feedback on achieving the goals using a dashboard with visualization tools within the mobile application.
Group II: Control armExperimental Treatment1 Intervention
Participants in the control group will be provided a smartwatch and home blood pressure monitor. They will also be provided with general instructions on how to download and install a physical activity and diet regulation applications (apps) available to the general public. They will still be asked to perform the blood pressure monitoring at regularly scheduled time periods, but do not receive the intervention components notifications in myBPmyLife app developed for the experimental group.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Dietary and physical activity JITAI delivered through the myBPmyLife app
2021
N/A
~610

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Common treatments for high blood pressure include lifestyle modifications and medications. Lifestyle changes such as reducing dietary salt intake and increasing physical activity can significantly lower blood pressure by decreasing blood volume and improving heart health. Medications like ACE inhibitors, beta-blockers, and diuretics work by relaxing blood vessels, reducing heart rate, and removing excess sodium and water from the body, respectively. Behavioral modifications through notifications, as studied in the Smartwatch and Mobile Health Application trial, are crucial because they help patients adhere to these lifestyle changes consistently, thereby enhancing the effectiveness of treatment and improving overall blood pressure control.
Precision Medicine for Hypertension Patients with Type 2 Diabetes via Reinforcement Learning.Determinants of hypertension treatment adherence among a Chinese population using the therapeutic adherence scale for hypertensive patients.Efficacy of Text Messaging and Personal Consultation by Pharmacy Students Among Adults With Hypertension: Randomized Controlled Trial.

Find a Location

Who is running the clinical trial?

University of MichiganLead Sponsor
1,833 Previous Clinical Trials
6,422,520 Total Patients Enrolled
American Heart AssociationOTHER
343 Previous Clinical Trials
4,970,990 Total Patients Enrolled
Brahmajee K Nallamothu, MDPrincipal InvestigatorUniversity of Michigan

Media Library

High Blood Pressure Research Study Groups: Control arm, Dietary plus physical activity JITAI
~166 spots leftby Sep 2025